Wuhan Hiteck Biological Pharma Co.,Ltd. Posted 1.7 Million Yuan Net Loss in First Quarter of 2023

Wuhan Hiteck Biological Pharma Co.,Ltd. (武汉海特生物制药股份有限公司) (300683.SZ) reported a net loss of 1.7 million yuan in the first quarter of 2023, reversing a net profit of 10.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 138.6 million yuan in revenue, down 16.6% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 384.6 million yuan in total liabilities, with a liability-to-asset ratio of 12.8%.